The Office for Life Sciences (OLS) is a joint unit between the Department of Health & Social Care (DHSC) and the Department for Business, Energy & Industrial Strategy (BEIS).
Medilink shares this bulletin with its members and networks to keep the life sciences sector up to date on the latest guidance as we approach the end of the Transition Period and during the Coronavirus (COVID-19) outbreak, providing you with information from the Government to help our members and networks prepare.
Including free business support webinars, business funding support, updated MHRA guidance on medical devices given exceptional use
authorisations during the COVID-19 pandemic, and updated MHRA clinical trials app.
To view the bulletin click here